NVO logo

Novo Nordisk A/S (NVO) Cash From Operations

Annual CFO

$17.55 B
+$1.74 B+11.00%

December 31, 2024

Summary

Performance

1-Year Change

+11%

3-Year Change

+100.55%

5-Year Change

+150.21%

15-Year Change

+180.08%

NVO Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.84%
NVO annual cash flow from operations is higher than 99.84% of companies in Healthcare sector

High & Low

All-time High

$17.55 B
NVO annual cash flow from operations is currently at an all-time high

3-Year Low

$8.75 B
NVO annual cash flow from operations is currently +100.55% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
NVO previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
NVO next annual earnings announcement has not yet been scheduled

OtherNVOcash flowmetrics:

Annual CFI

-$18.70 B
NVO annual cash flow from investing activities is -$18.70 billion

Annual CFF

$1.27 B
NVO annual cash flow from financing activities is $1.27 billion

Annual FCF

$10.11 B
NVO annual free cash flow is $10.11 billion

Annual CAPEX

$7.44 B
NVO annual capital expenditures is $7.44 billion

Quarterly CFO

$1.54 B
-$5.12 B-76.92%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-78.87%

3-Year Change

+444.25%

5-Year Change

+88.54%

NVO Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

98.69%
NVO quarterly cash flow from operations is higher than 98.69% of companies in Healthcare sector

High & Low

All-time High

$7.27 B
NVO quarterly cash flow from operations is currently -78.87% below its historical high of $7.27 billion

3-Year Low

-$446.39 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NVO previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
NVO next earnings announcement has not yet been scheduled

OtherNVOcash flowmetrics:

Quarterly CFI

-$13.15 B
NVO quarterly cash flow from investing activities is -$13.15 billion

Quarterly CFF

$5.41 B
NVO quarterly cash flow from financing activities is $5.41 billion

Quarterly FCF

-$786.37 M
NVO quarterly free cash flow is -$786.37 million

Quarterly CAPEX

$2.32 B
NVO quarterly capital expenditures is $2.32 billion

TTM CFO

$17.55 B
+$234.22 M+1.35%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+5.51%

3-Year Change

+100.55%

5-Year Change

+150.21%

NVO TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.83%
NVO TTM cash flow from operations is higher than 99.83% of companies in Healthcare sector

High & Low

All-time High

$17.55 B
NVO TTM cash flow from operations is currently at an all-time high

3-Year Low

$8.75 B
NVO TTM cash flow from operations is currently +100.55% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NVO previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
NVO next earnings announcement has not yet been scheduled

OtherNVOcash flowmetrics:

TTM CFI

-$18.70 B
NVO TTM cash flow from investing activities is -$18.70 billion

TTM CFF

$1.27 B
NVO TTM cash flow from financing activities is $1.27 billion

TTM FCF

$10.11 B
NVO TTM free cash flow is $10.11 billion

TTM CAPEX

$7.44 B
NVO TTM capital expenditures is $7.44 billion

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

NVO Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+11.0%-78.9%+5.5%
3 y3 years+100.5%+444.3%+100.5%
5 y5 years+150.2%+88.5%+150.2%

NVO Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+100.5%-78.9%+444.3%at high+100.5%
5 y5-yearat high+150.2%-78.9%+444.3%at high+151.2%
alltimeall timeat high+9338.3%-78.9%+444.3%at high+7700.7%

Novo Nordisk A/S Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
$17.55 B(+11.0%)
$1.54 B(-76.9%)
$17.55 B(+1.4%)
Sep 2024
-
$6.66 B(-8.4%)
$17.32 B(+4.1%)
Jun 2024
-
$7.27 B(+248.7%)
$16.63 B(+22.3%)
Mar 2024
-
$2.08 B(+60.1%)
$13.60 B(-14.0%)
Dec 2023
$15.81 B(+41.4%)
$1.30 B(-78.2%)
$15.81 B(-1.0%)
Sep 2023
-
$5.98 B(+41.1%)
$15.97 B(+23.7%)
Jun 2023
-
$4.23 B(-1.5%)
$12.91 B(+8.3%)
Mar 2023
-
$4.30 B(+193.6%)
$11.92 B(+6.6%)
Dec 2022
$11.18 B(+27.8%)
$1.46 B(-49.7%)
$11.18 B(+20.6%)
Sep 2022
-
$2.91 B(-10.4%)
$9.27 B(-3.8%)
Jun 2022
-
$3.25 B(-8.7%)
$9.64 B(-8.0%)
Mar 2022
-
$3.56 B(-897.1%)
$10.49 B(+19.8%)
Dec 2021
$8.75 B(+9.9%)
-$446.39 M(-113.6%)
$8.75 B(-3.0%)
Sep 2021
-
$3.28 B(-19.8%)
$9.02 B(+2.4%)
Jun 2021
-
$4.09 B(+124.3%)
$8.82 B(+6.1%)
Mar 2021
-
$1.82 B(-1147.5%)
$8.31 B(+4.4%)
Dec 2020
$7.96 B(+13.5%)
-$174.18 M(-105.7%)
$7.96 B(-11.1%)
Sep 2020
-
$3.07 B(-14.3%)
$8.95 B(+7.5%)
Jun 2020
-
$3.58 B(+142.4%)
$8.33 B(+19.1%)
Mar 2020
-
$1.48 B(+81.4%)
$6.99 B(-0.4%)
Dec 2019
$7.01 B(-0.7%)
$815.04 M(-66.7%)
$7.01 B(-6.0%)
Sep 2019
-
$2.45 B(+9.1%)
$7.47 B(+11.1%)
Jun 2019
-
$2.25 B(+49.2%)
$6.72 B(-3.4%)
Mar 2019
-
$1.51 B(+18.9%)
$6.95 B(-1.6%)
Dec 2018
$7.07 B(+12.8%)
$1.27 B(-25.6%)
$7.07 B(+8.5%)
Sep 2018
-
$1.70 B(-31.4%)
$6.52 B(-8.0%)
Jun 2018
-
$2.48 B(+53.2%)
$7.08 B(+15.1%)
Mar 2018
-
$1.62 B(+126.9%)
$6.15 B(-1.8%)
Dec 2017
$6.27 B(-12.7%)
$713.69 M(-68.5%)
$6.27 B(-12.5%)
Sep 2017
-
$2.27 B(+46.2%)
$7.16 B(+0.4%)
Jun 2017
-
$1.55 B(-10.5%)
$7.13 B(-8.7%)
Mar 2017
-
$1.73 B(+7.7%)
$7.81 B(+8.7%)
Dec 2016
$7.18 B(+26.1%)
$1.61 B(-28.1%)
$7.18 B(+1.5%)
Sep 2016
-
$2.24 B(+0.3%)
$7.07 B(+6.4%)
Jun 2016
-
$2.23 B(+101.8%)
$6.65 B(+7.6%)
Mar 2016
-
$1.11 B(-26.4%)
$6.18 B(+8.5%)
Dec 2015
$5.70 B(+0.8%)
$1.50 B(-17.2%)
$5.70 B(+3.4%)
Sep 2015
-
$1.81 B(+3.1%)
$5.51 B(-4.9%)
Jun 2015
-
$1.76 B(+182.9%)
$5.79 B(+4.8%)
Mar 2015
-
$621.90 M(-52.7%)
$5.53 B(-2.2%)
Dec 2014
$5.65 B(+22.4%)
$1.32 B(-37.3%)
$5.65 B(+6.6%)
Sep 2014
-
$2.10 B(+40.3%)
$5.30 B(+22.0%)
Jun 2014
-
$1.49 B(+100.0%)
$4.35 B(+5.6%)
Mar 2014
-
$746.96 M(-22.5%)
$4.12 B(-10.9%)
Dec 2013
$4.62 B(+20.4%)
$963.64 M(-15.6%)
$4.62 B(+15.0%)
Sep 2013
-
$1.14 B(-9.6%)
$4.02 B(-3.2%)
Jun 2013
-
$1.26 B(+1.0%)
$4.15 B(+1.2%)
Mar 2013
-
$1.25 B(+246.5%)
$4.10 B(+6.9%)
Dec 2012
$3.84 B
$361.06 M(-71.7%)
$3.84 B(-8.0%)
DateAnnualQuarterlyTTM
Sep 2012
-
$1.28 B(+5.0%)
$4.17 B(-3.8%)
Jun 2012
-
$1.21 B(+23.3%)
$4.33 B(+7.2%)
Mar 2012
-
$985.15 M(+42.0%)
$4.04 B(+1.2%)
Dec 2011
$3.99 B(+14.0%)
$693.76 M(-51.8%)
$3.99 B(-5.9%)
Sep 2011
-
$1.44 B(+55.9%)
$4.24 B(+8.2%)
Jun 2011
-
$923.02 M(-1.5%)
$3.92 B(+7.3%)
Mar 2011
-
$937.16 M(-0.5%)
$3.65 B(+4.3%)
Dec 2010
$3.50 B(+21.7%)
$942.33 M(-15.6%)
$3.50 B(+10.4%)
Sep 2010
-
$1.12 B(+69.7%)
$3.17 B(+2.8%)
Jun 2010
-
$657.87 M(-16.4%)
$3.09 B(+5.1%)
Mar 2010
-
$786.73 M(+28.5%)
$2.94 B(+2.1%)
Dec 2009
$2.88 B(+13.3%)
$612.27 M(-40.5%)
$2.88 B(+0.5%)
Sep 2009
-
$1.03 B(+102.1%)
$2.86 B(+13.5%)
Jun 2009
-
$509.37 M(-29.9%)
$2.52 B(-4.8%)
Mar 2009
-
$726.90 M(+21.8%)
$2.65 B(+4.3%)
Dec 2008
$2.54 B(+38.2%)
$596.86 M(-13.3%)
$2.54 B(+5.9%)
Sep 2008
-
$688.78 M(+8.0%)
$2.40 B(+1.2%)
Jun 2008
-
$637.83 M(+3.4%)
$2.37 B(+18.1%)
Mar 2008
-
$617.11 M(+35.3%)
$2.01 B(+9.2%)
Dec 2007
$1.84 B(+41.0%)
$456.16 M(-30.9%)
$1.84 B(+29.0%)
Sep 2007
-
$659.79 M(+140.6%)
$1.43 B(+3.6%)
Jun 2007
-
$274.19 M(-38.9%)
$1.38 B(-2.8%)
Mar 2007
-
$448.42 M(+942.6%)
$1.41 B(+8.5%)
Dec 2006
$1.30 B(-10.3%)
$43.01 M(-93.0%)
$1.30 B(-22.2%)
Sep 2006
-
$610.21 M(+94.8%)
$1.68 B(+10.1%)
Jun 2006
-
$313.17 M(-7.2%)
$1.52 B(-2.0%)
Mar 2006
-
$337.39 M(-18.7%)
$1.55 B(+6.9%)
Dec 2005
$1.45 B(+13.6%)
$414.94 M(-9.1%)
$1.45 B(+3.4%)
Sep 2005
-
$456.40 M(+32.4%)
$1.41 B(+3.0%)
Jun 2005
-
$344.65 M(+45.4%)
$1.36 B(+5.7%)
Mar 2005
-
$237.06 M(-35.4%)
$1.29 B(+0.9%)
Dec 2004
$1.28 B(+35.9%)
$367.04 M(-11.8%)
$1.28 B(+40.3%)
Sep 2004
-
$416.08 M(+53.8%)
$911.53 M(+84.0%)
Jun 2004
-
$270.45 M(+20.2%)
$495.45 M(+120.2%)
Mar 2004
-
$224.99 M
$224.99 M
Dec 2003
$940.61 M(+51.6%)
-
-
Dec 2002
$620.55 M(+19.8%)
-
-
Dec 2001
$518.07 M(-20.6%)
-
-
Dec 2000
$652.20 M(+60.6%)
-
-
Dec 1999
$406.08 M(+11.1%)
-
-
Dec 1998
$365.54 M(-20.5%)
-
-
Dec 1997
$459.82 M(+38.7%)
-
-
Dec 1996
$331.58 M(-26.6%)
-
-
Dec 1995
$451.90 M(+7.7%)
-
-
Dec 1994
$419.67 M(+42.1%)
-
-
Dec 1993
$295.30 M(+33.9%)
-
-
Dec 1992
$220.47 M(+18.6%)
-
-
Dec 1991
$185.96 M(-23.7%)
-
-
Dec 1990
$243.65 M
-
-

FAQ

  • What is Novo Nordisk A/S annual cash flow from operations?
  • What is the all time high annual CFO for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual CFO year-on-year change?
  • What is Novo Nordisk A/S quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly CFO year-on-year change?
  • What is Novo Nordisk A/S TTM cash flow from operations?
  • What is the all time high TTM CFO for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM CFO year-on-year change?

What is Novo Nordisk A/S annual cash flow from operations?

The current annual CFO of NVO is $17.55 B

What is the all time high annual CFO for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual cash flow from operations is $17.55 B

What is Novo Nordisk A/S annual CFO year-on-year change?

Over the past year, NVO annual cash flow from operations has changed by +$1.74 B (+11.00%)

What is Novo Nordisk A/S quarterly cash flow from operations?

The current quarterly CFO of NVO is $1.54 B

What is the all time high quarterly CFO for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly cash flow from operations is $7.27 B

What is Novo Nordisk A/S quarterly CFO year-on-year change?

Over the past year, NVO quarterly cash flow from operations has changed by -$5.73 B (-78.87%)

What is Novo Nordisk A/S TTM cash flow from operations?

The current TTM CFO of NVO is $17.55 B

What is the all time high TTM CFO for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM cash flow from operations is $17.55 B

What is Novo Nordisk A/S TTM CFO year-on-year change?

Over the past year, NVO TTM cash flow from operations has changed by +$917.27 M (+5.51%)